
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Analysis of [ADAP] Adaptimmune Therapeutics plc
Data updated 2025-Sep-29 (Monday)Quick Instructional video for this page. Collapse this after viewing by clicking How-to button above. Open in new tab
Share
2025-Sep-29 Monday
Open | $0.16 | High | $0.16 +4.76% |
---|---|---|---|
Close | $0.14 | Low | $0.13 -14.29% |
Volume | 43.9 Million 0.27x | Volatility | 22.23% |
Change |
$-0.01
-4.76%
|
Streak | ↓ 1 days -4.76% |
20d SMA | $0.09 +51.2% | 50d SMA | $0.10 +33.7% | 100d SMA | $0.19 -25.0% | 200d SMA | $0.33 -57.0% |
RSI | 59 | MACD | 0.01 | ADX | 39.2 | Stochastic Oscillator | 52.0 52.2 |
CCI | 80.9 | ATR | 0.03 | OBV | 1.59 Billion | Chaikin A/D | -1.09 Billion |
Market Cap | 341 M | PEG Ratio | Trailing P/E | Forward P/E | |||
Price/Sales (ttm) | 4.6 | Price/Book (mrq) | 8.62 | EV/Revenue (ttm) | 3.63 | EV/EBITDA (ttm) | -1.71 |
% Held by Insiders | 0.21% | % Held by Institutions | 70.02% | Shares Short | 3.11 M | Shares Short (prior month) | 2.93 M |
Short Ratio | 1.55 | Short % of Outstanding | 1.26% | Short % of Float | 0.47% | Shares Short Change (mom) | +6.1% |
Revenue/Share (ttm) | $0.30 | Profit Margin (ttm) | -188.90% | Operating Margin (ttm) | EBITDA (ttm) | -128 M | |
Diluted EPS (ttm) | $-0.54 | Current Ratio (mrq) | 2.85 | Return on Assets (ttm) | -28.22% | Return on Equity (ttm) | -187.61% |
Qtr Earnings Growth (yoy) | Qtr Revenue Growth (yoy) | -97.90% | Operating Cash Flow (ttm) | -141 M | Free Cash Flow (ttm) | -73.8 M | |
Choose view type
Daily Performance for Adaptimmune Therapeutics plc. Click on candlesticks in Chart to show/hide summary for day or navigate to historical record (Time Machine functionality)
Note: Performance over Key Timeperiods for Adaptimmune Therapeutics plc up to close of 2025-Sep-29 at $0.14
Period | Frequency | Performance | % off High | % off Low | Volatility | % off SMA | % off EMA | Relative Volume |
---|---|---|---|---|---|---|---|---|
01 Trailing 5-days
|
|
-16.37%
|
-23.7%
|
+19.7%
|
50.0%
|
+0.1%
|
+0.8%
|
0.27x
|
02 Trailing 10-days
|
|
+110.21%
|
-37.8%
|
+90.5%
|
228.6%
|
+4.9%
|
+9.8%
|
1.72x
|
03 Trailing 20-days
|
|
+137.69%
|
-37.8%
|
+247.4%
|
475.0%
|
+51.2%
|
+27.2%
|
1.43x
|
04 Trailing 30-days
|
|
+135.29%
|
-37.8%
|
+247.4%
|
475.0%
|
+70.5%
|
+30.0%
|
1.27x
|
05 Trailing 50-days
|
|
-49.91%
|
-60.9%
|
+247.4%
|
800.0%
|
+33.7%
|
+14.4%
|
1.98x
|
06 Trailing 100-days
|
|
-53.33%
|
-60.9%
|
+247.4%
|
800.0%
|
-25.0%
|
-24.9%
|
1.93x
|
07 Trailing 200-days
|
|
-77.64%
|
-79.6%
|
+247.4%
|
1,625.0%
|
-57.0%
|
-58.0%
|
1.23x
|
08 Month-to-date
|
|
+137.69%
|
-37.8%
|
+247.4%
|
475.0%
|
|
|
|
09 Quarter-to-date
|
|
-41.59%
|
-60.9%
|
+247.4%
|
800.0%
|
|
|
|
10 Year-to-date
|
|
-74.01%
|
-79.6%
|
+247.4%
|
1,625.0%
|
|
|
|
11 Trailing 52-weeks
|
|
-85.67%
|
-86.0%
|
+247.4%
|
2,400.0%
|
|
|
|
3-month Performance Benchmarks for Adaptimmune Therapeutics plc:
Related to Adaptimmune Therapeutics plc
Information for Adaptimmune Therapeutics plc
Current Detail : Recent daily/monthly performance & benchmark comparison Currently Viewing
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Sep-29 on Google
SEC Reports : Quarterly reports around 2025-Sep-29 on SEC Edgar
Compare Adaptimmune Therapeutics plc with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc